SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 102 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183,890 | +15.5% | 25,900 | +22.6% | 0.00% | – |
| Q2 2023 | $159,275 | +360.0% | 21,124 | +388.1% | 0.00% | – |
| Q1 2023 | $34,624 | +235.0% | 4,328 | +279.0% | 0.00% | – |
| Q4 2022 | $10,335 | +106.7% | 1,142 | +56.0% | 0.00% | – |
| Q3 2022 | $5,000 | -16.7% | 732 | -29.1% | 0.00% | – |
| Q2 2022 | $6,000 | -70.0% | 1,032 | +45.8% | 0.00% | – |
| Q2 2021 | $20,000 | -81.0% | 708 | -87.8% | 0.00% | – |
| Q2 2020 | $105,000 | +22.1% | 5,785 | -18.2% | 0.00% | – |
| Q1 2020 | $86,000 | -66.8% | 7,070 | -64.0% | 0.00% | – |
| Q4 2019 | $259,000 | +91.9% | 19,636 | +30.1% | 0.00% | – |
| Q3 2019 | $135,000 | +150.0% | 15,091 | +346.5% | 0.00% | – |
| Q2 2019 | $54,000 | +1.9% | 3,380 | +47.1% | 0.00% | – |
| Q4 2018 | $53,000 | +39.5% | 2,298 | +56.6% | 0.00% | – |
| Q3 2018 | $38,000 | -19.1% | 1,467 | -51.3% | 0.00% | – |
| Q2 2018 | $47,000 | – | 3,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
| Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
| Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
| Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
| Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
| Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
| Atom Investors LP | 25,839 | $333,000 | 0.16% |
| GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
| Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
| Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |